Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer.
Nature Communications
Pereira, Bernard B; Chen, Christopher T CT; Goyal, Lipika L; Walmsley, Charlotte C; Pinto, Christopher J CJ; Baiev, Islam I; Allen, Read R; Henderson, Laura L; Saha, Supriya S; Reyes, Stephanie S; Taylor, Martin S MS; Fitzgerald, Donna M DM; Broudo, Maida Williams MW; Sahu, Avinash A; Gao, Xin X; Winckler, Wendy W; Brannon, A Rose AR; Engelman, Jeffrey A JA; Leary, Rebecca R; Stone, James R JR; Campbell, Catarina D CD; Juric, Dejan D
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
Journal For Immunotherapy Of Cancer
Blumendeller, Carolin C; Boehme, Julius J; Frick, Maximilian M; Schulze, Martin M; Rinckleb, Antje A; Kyzirakos, Christina C; Kayser, Simone S; Kopp, Maria M; Kelkenberg, Sabine S; Pieper, Natalia N; Bartsch, Oliver O; Hadaschick, Dirk D; Battke, Florian F; Stenzl, Arnulf A; Biskup, Saskia S